Optic neuritis

被引:108
作者
Pau, D. [1 ]
Al Zubidi, N. [1 ]
Yalamanchili, S. [1 ]
Plant, G. T. [2 ,3 ,4 ]
Lee, A. G. [1 ,5 ,6 ,7 ]
机构
[1] Methodist Hosp, Dept Ophthalmol, Houston, TX 77030 USA
[2] Moorfields Eye Hosp, London, England
[3] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[4] St Thomas Hosp, London, England
[5] Weill Cornell Med Coll, Dept Ophthalmol Neurol & Neurosurg, New York, NY USA
[6] Univ Iowa Hosp & Clin, Dept Ophthalmol, Iowa City, IA 52242 USA
[7] Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX USA
关键词
optic neuritis; multiple sclerosis; neuromyelitis optica; demyelinating optic neuritis; visual loss; DEVELOPING MULTIPLE-SCLEROSIS; REVISED DIAGNOSTIC-CRITERIA; FOLLOW-UP-REPORT; TREATMENT-TRIAL; NEUROMYELITIS-OPTICA; RANDOMIZED-TRIAL; VISUAL FUNCTION; CEREBROSPINAL-FLUID; PLASMA-EXCHANGE; AXONAL LOSS;
D O I
10.1038/eye.2011.81
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims The aim of this study is to provide a clinical update on optic neuritis (ON), its association with multiple sclerosis (MS), and neuromyelitis optica (NMO). Methods This study included a PubMed review of the literature written in the English language. Results ON in adults is typically idiopathic or demyelinating, and is characterised by unilateral, subacute, painful loss of vision that is not associated with any systemic or other neurological symptoms. Demyelinating ON is associated with MS, and we review the key studies of ON including the ON treatment trial and several other MS treatment trials and NMO. Conclusion Acute demyelinating ON can occur in isolation or be associated with MS. Typical ON does not require additional evaluation other than cranial magnetic resonance imaging. NMO is likely a separate disorder from MS and the ON in NMO has a different treatment and prognosis. Methodology The authors conducted an English language search using Pubmed from the years 1964 to 2010 using the search terms 'ON', 'MS' and 'NMO'. The authors included original articles, review articles, and case reports, which revealed new aspects as far as epidemiology, histopathology, clinical manifestations, imaging, genetics, and treatment of ON. Titles were reviewed for topicality and full references were obtained. Letters to the editor, unpublished work, and abstracts were not included in this review. Eye (2011) 25, 833-842; doi: 10.1038/eye.2011.81; published online 29 April 2011
引用
收藏
页码:832 / 841
页数:10
相关论文
共 81 条
[31]   The Controlled High Risk Avonex® Multiple Sclerosis Trial (CHAMPS STUDY) [J].
Galetta, SL .
JOURNAL OF NEURO-OPHTHALMOLOGY, 2001, 21 (04) :292-295
[32]  
GOLDSTEIN JE, 1964, ARCH OPHTHALMOL-CHIC, V72, P168
[33]   Perils and pitfalls in the interpretation of clinical trials: A reflection on the recent experience in multiple sclerosis [J].
Goodin, DS .
NEUROEPIDEMIOLOGY, 1999, 18 (02) :53-63
[34]   Optic Neuritis: An Update Typical and Atypical Optic Neuritis [J].
Hickman, Simon J. ;
Ko, Michael ;
Chaudhry, Frasat ;
Jay, Walter M. ;
Plant, Gordon T. .
NEURO-OPHTHALMOLOGY, 2008, 32 (05) :237-248
[35]   Management of acute optic neuritis [J].
Hickman, SJ ;
Dalton, CM ;
Miller, DH ;
Plant, GT .
LANCET, 2002, 360 (9349) :1953-1962
[36]   Seasonal patterns in optic neuritis and multiple sclerosis:: a meta-analysis [J].
Jin, YP ;
de Pedro-Cuesta, J ;
Söderström, M ;
Stawiarz, L ;
Link, H .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 181 (1-2) :56-64
[37]   Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis:: a 3-year follow-up analysis of the BENEFIT study [J].
Kappos, Ludwig ;
Freedman, Mark S. ;
Polman, Chris H. ;
Edan, Gilles ;
Hartung, Hans-Peter ;
Miller, David H. ;
Montalban, Xavier ;
Barkhof, Frederik ;
Radu, Ernst-Wilheim ;
Bauer, Lars ;
Dahms, Susanne ;
Lanius, Vivian ;
Pohl, Christoph ;
Sandbrink, Rupert .
LANCET, 2007, 370 (9585) :389-397
[38]   Optic neuritis and the neuro-ophthalmology of multiple sclerosis [J].
Kaur, Paramjit ;
Bennett, Jeffrey L. .
NEUROBIOLOGY OF MULTIPLE SCLEROSIS, 2007, 79 :633-+
[39]  
Kawasaki A, 1999, Curr Opin Ophthalmol, V10, P394, DOI 10.1097/00055735-199912000-00005
[40]   Visual Field Profile of Optic Neuritis A Final Follow-up Report From the Optic Neuritis Treatment Trial From Baseline Through 15 Years [J].
Keltner, John L. ;
Johnson, Chris A. ;
Cello, Kimberly E. ;
Dontchev, Mariya ;
Gal, Robin L. ;
Beck, Roy W. .
ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (03) :330-337